Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study
Condition(s):AsthmaLast Updated:June 23, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):AsthmaLast Updated:June 23, 2021Unknown status
Condition(s):ObesityLast Updated:June 7, 2023Completed
Condition(s):Diabete Mellitus; Pre-diabetes; Healthy; Hypertension; Dyslipidemia Associated With Type II Diabetes MellitusLast Updated:December 28, 2023Recruiting
Condition(s):Strains ThighLast Updated:October 4, 2021Completed
Condition(s):Plantar Fascitis; Surgical Treatment; Non-operative Treatment; Randomized StudyLast Updated:March 8, 2023Withdrawn
Condition(s):Overweight/Obesity; Prediabetes; Weight ManagementLast Updated:November 28, 2023Recruiting
Condition(s):Alcohol Use Disorder; PTSD; Cognitive DysfunctionLast Updated:February 11, 2021Completed
Condition(s):Post Liver Transplantation Weight Gain; Post Liver Transplantation Obesity; Nonalcoholic SteatohepatitisLast Updated:October 10, 2017Terminated
Condition(s):Cardiac RehabilitationLast Updated:April 4, 2016Completed
Condition(s):TelemedicineLast Updated:September 13, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.